Philippe Bonniaud,Carmen Garrido,Guillaume Wettstein
申请号：
US14573145
公开号：
US09326993B2
申请日:
2014.12.17
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Reduction of HSP27 expression is in beneficial in the treatment of pleural and pulmonary fibrosis and in particular subpleural fibrosis and IPF. Pharmaceutical compositions for this purpose contain an inhibitor of HSP27 and a pharmaceutically acceptable carrier.
